BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Bacigalupo ML, Carabias P, Troncoso MF. Contribution of galectin-1, a glycan-binding protein, to gastrointestinal tumor progression. World J Gastroenterol 2017; 23(29): 5266-5281 [PMID: 28839427 DOI: 10.3748/wjg.v23.i29.5266]
URL: https://www.wjgnet.com/1007-9327/full/v23/i29/5266.htm
Number Citing Articles
1
Peng Zhao, Fei Lan, Hui Zhang, Guangwei Zeng, Dong Liu. Down‐regulation of KIF2A inhibits gastric cancer cell invasion via suppressing MT1‐MMPClinical and Experimental Pharmacology and Physiology 2018; 45(10): 1010 doi: 10.1111/1440-1681.12974
2
Ashraf A. Noah, Nesrine S. El-Mezayen, Samar O. El-Ganainy, Inas E. Darwish, Elham A. Afify. Reversal of fibrosis and portal hypertension by Empagliflozin treatment of CCl4-induced liver fibrosis: Emphasis on gal-1/NRP-1/TGF-β and gal-1/NRP-1/VEGFR2 pathwaysEuropean Journal of Pharmacology 2023; 959: 176066 doi: 10.1016/j.ejphar.2023.176066
3
Liewen Lin, Ligang Xia, Donge Tang, Yong Dai, Wenbiao Chen. Analysis of autophagy-related genes and associated noncoding RNAs and transcription factors in digestive system tumorsFuture Oncology 2019; 15(36): 4141 doi: 10.2217/fon-2019-0341
4
Shuai Huang, Xiangkun Wang, Kai Luo, Xudong Zhang, Zhongyuan Liu, Renfeng Li, Shao Liang. Combined Evaluation of mRNA and Protein Expression, Promoter Methylation, and Immune Infiltration of UBE2I in Pan-Digestive System TumorsOxidative Medicine and Cellular Longevity 2022; 2022: 1 doi: 10.1155/2022/1129062
5
Bo Long, Zeyuan Yu, Huinian Zhou, Zhijian Ma, Yanxian Ren, Hao Zhan, Long Li, Hongtai Cao, Zuoyi Jiao. Clinical characteristics and prognostic significance of galectins for patients with gastric cancer: A meta-analysisInternational Journal of Surgery 2018; 56: 242 doi: 10.1016/j.ijsu.2018.06.033
6
Pablo Carabias, María V. Espelt, María L. Bacigalupo, Paola Rojas, Luciana Sarrias, Ayelén Rubin, Nicolás A. Saffioti, María T. Elola, Juan P. Rossi, Carlota Wolfenstein-Todel, Gabriel A. Rabinovich, María F. Troncoso. Galectin-1 confers resistance to doxorubicin in hepatocellular carcinoma cells through modulation of P-glycoprotein expressionCell Death & Disease 2022; 13(1) doi: 10.1038/s41419-022-04520-6
7
Ana Bogut, Bojan Stojanovic, Marina Jovanovic, Milica Dimitrijevic Stojanovic, Nevena Gajovic, Bojana S. Stojanovic, Goran Balovic, Milan Jovanovic, Aleksandar Lazovic, Milos Mirovic, Milena Jurisevic, Ivan Jovanovic, Violeta Mladenovic. Galectin-1 in Pancreatic Ductal Adenocarcinoma: Bridging Tumor Biology, Immune Evasion, and Therapeutic OpportunitiesInternational Journal of Molecular Sciences 2023; 24(21): 15500 doi: 10.3390/ijms242115500
8
Fang Sun, Jin-Zhi Wang, Ji-Jun Luo, Yu-Qin Wang, Qin Pan. Exosomes in the Oncobiology, Diagnosis, and Therapy of Hepatic Carcinoma: A New Player of an Old GameBioMed Research International 2018; 2018: 1 doi: 10.1155/2018/2747461
9
Yi Gao, Song-Guo Li, Qian Liu, Sheng-Sheng Liu, Lei Ye, Zi-Jian Song, Wei-Dong Du. Establishment of a 1, 4, 7, 10-tetraazacyclododecane-1,4,7,10-tetraacetic acid mono-N-hydroxysuccinimide ester (DOTA–NHS–ester) based lectin microarray for efficiently detecting serum glycans in gastric cancersAnalytical Biochemistry 2020; 597: 113686 doi: 10.1016/j.ab.2020.113686
10
Hong Peng, Ru Chen, Sheng Pan. Oncogenomics2019; : 299 doi: 10.1016/B978-0-12-811785-9.00021-1
11
Chen Zeng, Ran Yan, Guanghua Yang, Sen Xiang, Fuli Zhao. Hedgehog signaling activation required for glypican-6-mediated regulation of invasion, migration, and epithelial–mesenchymal transition of gastric cancer cellsBioscience Reports 2020; 40(6) doi: 10.1042/BSR20193181
12
Jose Francisco Islas, Adriana G. Quiroz-Reyes, Paulina Delgado-Gonzalez, Hector Franco-Villarreal, Juan Luis Delgado-Gallegos, Elsa N. Garza-Treviño, Carlos A. Gonzalez-Villarreal. Cancer Stem Cells in Tumor Microenvironment of Adenocarcinoma of the Stomach, Colon, and RectumCancers 2022; 14(16): 3948 doi: 10.3390/cancers14163948
13
Zhengting Jiang, Wenjie Zhang, Gengyu Sha, Daorong Wang, Dong Tang. Galectins Are Central Mediators of Immune Escape in Pancreatic Ductal AdenocarcinomaCancers 2022; 14(22): 5475 doi: 10.3390/cancers14225475
14
Hongna Zheng, Yan Cui, Xuena Li, Bulin Du, Yaming Li. Prognostic Significance of 18F-FDG PET/CT Metabolic Parameters and Tumor Galectin-1 Expression in Patients With Surgically Resected Lung AdenocarcinomaClinical Lung Cancer 2019; 20(6): 420 doi: 10.1016/j.cllc.2019.04.002
15
Shovonlal Bhowmick, Achintya Saha, Nora Abdullah AlFaris, Jozaa Zaidan ALTamimi, Zeid A. ALOthman, Tahany Saleh Aldayel, Saikh Mohammad Wabaidur, Md Ataul Islam. Structure-based identification of galectin-1 selective modulators in dietary food polyphenols: a pharmacoinformatics approachMolecular Diversity 2022; 26(3): 1697 doi: 10.1007/s11030-021-10297-1
16
Alejandro J. Cagnoni, María Laura Giribaldi, Ada G. Blidner, Anabela M. Cutine, Sabrina G. Gatto, Rosa M. Morales, Mariana Salatino, Martín C. Abba, Diego O. Croci, Karina V. Mariño, Gabriel A. Rabinovich. Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8 + regulatory T cells Proceedings of the National Academy of Sciences 2021; 118(21) doi: 10.1073/pnas.2102950118
17
Olga I. Urazova, Gleb V. Reyngardt, Yulia V. Kolobovnikova, Anna V. Kurnosenko, Vadim S. Poletika, Olga A. Vasil'yeva, Aleksandra V. Avgustinovich. The <i>LGALS1</i> gene polymorphism is not associated with galectin-1 levels in tumor tissue and blood of colon cancer patientsAlmanac of Clinical Medicine 2024;  doi: 10.18786/2072-0505-2024-52-006
18
Yu. V. Kolobovnikova, O. I. Urazova, V. S. Poletika, G. V. Reyngardt, E. V. Romanova, A. V. Kurnosenko, A. I. Dmitrieva, K. I. Yankovich, M. Yu. Grishchenko. Galectin-1 and Galectin-3 expression in colon cancer and its correlation with tumor invasion, differentiation, and metastatic spreadFundamental and Clinical Medicine 2021; 6(4): 45 doi: 10.23946/2500-0764-2021-6-4-45-53
19
Zhangyan Jing, Yuan Li, Yumeng Ma, Xiaozhou Zhang, Xin Liang, Xudong Zhang. Leverage biomaterials to modulate immunity for type 1 diabetesFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.997287